This week's roundup of Houston innovators includes Joy M. Hutton of Joy of Consulting, Michael T. Suffredini of Axiom Space, and Kim Raath of Topl. Courtesy photos

Editor's note: In the last weekly roundup of Houston innovators of 2020, I'm introducing you to three innovators across the city — the new local leader of a new Google program, the CEO of a space tech company, and a startup founder with fresh funds.

Joy M. Hutton, local leader of Grow with Google's Digital Coach program

Joy M. Hutton leads the Grow with Google in Houston. Photo courtesy of Google

Joy M. Hutton is a serial entrepreneur and has just signed on to help guide other startup founders as the local leader of the Grow with Google Digital Coach program in Houston. Just like any other entrepreneur this year, Hutton, who was planning to launch her company On the Go Glam in March, was challenged to pivot her own startup amid COVID-19 and its accompanying obstacles.

On this week's episode of the Houston Innovators Podcast, Hutton shares how the pandemic caused her to rethink the timeline on some of the features she had in mind for the company.

"The pandemic was kind of a good thing, because it allowed me to take a step back and add additional services for men," Hutton says, adding that expanding into offering barbershop services was always a plan, but the new need pushed her to quickly pivot. Read more and stream the episode.

Michael T. Suffredini, president and CEO of Axiom Space

Michael T. Suffredini co-founded Houston-based Axiom Space. Photo via AxiomSpace.com

A veteran of the space business, Michael T. Suffredini now leads Axiom Space, which just announced a partnership with the Houston Spaceport. Mayor Sylvester Turner announced that Axiom Space will construct a 14-acre headquarters.

The headquarters "will be the world's first free-flying internationally available private space station that will serve as humanity's central hub for research, manufacturing, and commerce," Turner said.

The partnership is expected to bring more than 1,000 high-paying jobs, from engineers to scientists, mathematicians, and machinists. Read more.

Kim Raath, CEO of Topl

Kim Raath is ending her year with news of a VC deal. Courtesy of Topl

Unfortunately, the pandemic has had its detrimental effect on venture capital — especially when it comes to female-founded companies. Crunchbase reported a 27 percent decrease in funding for female-founded companies.

In light of this statistic, Kim Raath, CEO and co-founder of Houston-based Topl, is feeling pretty proud of leading her company to closing a $3 million round with support from investors both locally and across the country.

"We're grateful to have closed an oversubscribed venture round during a pandemic, especially given the unfortunate truth that many women-led startups are getting much less investment during this time," says Kim Raath, CEO of Topl, in a press release. "Bringing transparency to causes dedicated to environmental and social good has never been more important. We are building a modern blockchain for a world where purpose and profit go hand in hand." Read more.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Axiom Space-tested cancer drug advances to clinical trials

mission critical

A cancer-fighting drug tested aboard several Axiom Space missions is moving forward to clinical trials.

Rebecsinib, which targets a cancer cloning and immune evasion gene, ADAR1, has received FDA approval to enter clinical trials under active Investigational New Drug (IND) status, according to a news release. The drug was tested aboard Axiom Mission 2 (Ax-2) and Axiom Mission 3 (Ax-3). It was developed by Aspera Biomedicine, led by Dr. Catriona Jamieson, director of the UC San Diego Sanford Stem Cell Institute (SSCI).

The San Diego-based Aspera team and Houston-based Axiom partnered to allow Rebecsinib to be tested in microgravity. Tumors have been shown to grow more rapidly in microgravity and even mimic how aggressive cancers can develop in patients.

“In terms of tumor growth, we see a doubling in growth of these little mini-tumors in just 10 days,” Jamieson explained in the release.

Rebecsinib took part in the patient-derived tumor organoid testing aboard the International Space Station. Similar testing is planned to continue on Axiom Station, the company's commercial space station that's currently under development.

Additionally, the drug will be tested aboard Ax-4 under its active IND status, which was targeted to launch June 25.

“We anticipate that this monumental mission will inform the expanded development of the first ADAR1 inhibitory cancer stem cell targeting drug for a broad array of cancers," Jamieson added.

According to Axiom, the milestone represents the potential for commercial space collaborations.

“We’re proud to work with Aspera Biomedicines and the UC San Diego Sanford Stem Cell Institute, as together we have achieved a historic milestone, and we’re even more excited for what’s to come,” Tejpaul Bhatia, the new CEO of Axiom Space, said in the release. “This is how we crack the code of the space economy – uniting public and private partners to turn microgravity into a launchpad for breakthroughs.”

Chevron enters the lithium market with major Texas land acquisition

to market

Chevron U.S.A., a subsidiary of Houston-based energy company Chevron, has taken its first big step toward establishing a commercial-scale lithium business.

Chevron acquired leaseholds totaling about 125,000 acres in Northeast Texas and southwest Arkansas from TerraVolta Resources and East Texas Natural Resources. The acreage contains a high amount of lithium, which Chevron plans to extract from brines produced from the subsurface.

Lithium-ion batteries are used in an array of technologies, such as smartwatches, e-bikes, pacemakers, and batteries for electric vehicles, according to Chevron. The International Energy Agency estimates lithium demand could grow more than 400 percent by 2040.

“This acquisition represents a strategic investment to support energy manufacturing and expand U.S.-based critical mineral supplies,” Jeff Gustavson, president of Chevron New Energies, said in a news release. “Establishing domestic and resilient lithium supply chains is essential not only to maintaining U.S. energy leadership but also to meeting the growing demand from customers.”

Rania Yacoub, corporate business development manager at Chevron New Energies, said that amid heightening demand, lithium is “one of the world’s most sought-after natural resources.”

“Chevron is looking to help meet that demand and drive U.S. energy competitiveness by sourcing lithium domestically,” Yacoub said.

---

This article originally appeared on EnergyCapital.